Antimicrobial Stewardship in Community Pharmacy

Sponsor
University of Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT04219553
Collaborator
(none)
188
2
2
6.2
94
15.1

Study Details

Study Description

Brief Summary

Acute otitis media (AOM) is the most common indication for antibiotics for Canadian paediatric patients. As the gatekeepers of safe and effective prescription pharmacotherapy, community pharmacists are well positioned to influence and optimize antibiotic use. The purpose of this project is to develop, implement, and evaluate an antimicrobial stewardship program in the community pharmacy setting that aims to optimize antibiotic use for AOM. This nonrandomized pre-post study includes children aged 6 months to 12 years presenting with an antibiotic prescription for AOM at two community pharmacies in Toronto, Ontario. Participants are excluded if they exhibit signs/symptoms of mastoiditis, have an additional indication for systemic antibiotics, or parents/guardians cannot consent in English. The multifaceted AMS intervention includes pharmacist education, a clinical decision support tool, a parent/guardian questionnaire, and individualized monthly audit and feedback with each pharmacist. Prescriptions are reviewed and adapted by the pharmacist to optimize congruence with 2016 Canadian Paediatric Society AOM guidelines. The primary outcome is the percentage change in guideline congruence attributable to pharmacist intervention. This study will provide insight into the opportunities and barriers of developing large-scale antimicrobial stewardship programs for community pharmacies.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Antimicrobial stewardship
  • Other: Comparator (no intervention)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
188 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pre-post intervention study modelPre-post intervention study model
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Moving Antimicrobial Stewardship Into Community Pharmacy: A Pre-post Study of Acute Otitis Media Management
Actual Study Start Date :
May 25, 2017
Actual Primary Completion Date :
Nov 15, 2017
Actual Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Retrospective group

Comparator group (pre-intervention)

Other: Comparator (no intervention)
No active intervention

Experimental: Prospective group

Study group (post-intervention)

Behavioral: Antimicrobial stewardship
The multifaceted AMS intervention includes pharmacist education, a clinical decision support tool, a parent/guardian questionnaire, and individualized monthly audit and feedback with each pharmacist.

Outcome Measures

Primary Outcome Measures

  1. Change in guideline congruence [Pre-post study intervention (comparison of two 4-6 month periods)]

    % change in guideline congruence for overall antibiotic prescriptions as attributable to pharmacist intervention before and after study intervention

Secondary Outcome Measures

  1. Choice of antibiotic [Pre-post study intervention (comparison of two 4-6 month periods)]

    % change in guideline congruence for choice of antibiotic before and after study intervention

  2. Antibiotic dosing [Pre-post study intervention (comparison of two 4-6 month periods)]

    % change in guideline congruence for antibiotic dose before and after study intervention

  3. Antibiotic duration [Pre-post study intervention (comparison of two 4-6 month periods)]

    % change in guideline congruence for antibiotic duration before and after study intervention

  4. Acceptance of pharmacist recommendations [Post-intervention study arm (6 month period after start of intervention)]

    The percentage of pharmacist recommendations that were accepted by prescribers and parents/guardians (descriptive statistic)

  5. Balancing measure: resolution of AOM [7-14 days after antibiotics were dispensed]

    The percent of cases with symptom resolution for AOM

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Months to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Prescribed systemic oral antibiotic therapy

  • Antibiotics are indicated for the treatment of acute otitis media (AOM) as reported verbally or in writing by parent/guardian or prescriber

Exclusion Criteria:
  • signs/symptoms of mastoiditis

  • a diagnosis in addition to AOM for which systemic antibiotics are indicated

  • parents/guardians cannot consent to the study in English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shoppers Drug Mart #500 Toronto Ontario Canada M4C 1H6
2 Shoppers Drug Mart #994 Toronto Ontario Canada M4J 1L2

Sponsors and Collaborators

  • University of Toronto

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Katherine Koroluk, Principal Investigator, University of Toronto
ClinicalTrials.gov Identifier:
NCT04219553
Other Study ID Numbers:
  • 34327
First Posted:
Jan 7, 2020
Last Update Posted:
Jan 7, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Katherine Koroluk, Principal Investigator, University of Toronto
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 7, 2020